Latest news
- Home
- Press Room
- Latest News
Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.
Omics and machine learning for rare genetic diseases
Dec. 13, 2021
Génome Québec would like to congratulate Alex Parker and Éric Samarut, researchers at the Centre de recherche du CHUM, who have received funding under the Genomics Integration Program - Human Health. Their project will be carried out in partnership with Modelis, a Québec-based biotechnology company. This innovative project integrating artificial intelligence and omics data aims to accelerate the discovery of new drugs for rare genetic diseases and drastically reduce the costs of pre-clinical studies.
Génome Québec and the Fonds de recherche – Nature et technologies announce a $2.6 M partnership to support innovation as part of the economic recovery initiative
Oct. 21, 2021
Génome Québec and the Fonds de recherche du Québec – Nature et technologies (FRQNT) have joined forces for the first edition of the Geonomics integration program – agriculture and biofood, forestry and environment. The budget for this program comes from a $2 M investment from Génome Québec and a $600,000 investment from FRQNT as part of the economic recovery initiative in the biofood and green energy sectors.
For Stéphanie Lord-Fontaine, Vice President, Scientific Affairs at Génome Québec, “it goes without saying that innovation starts with great ideas, but you also need to have the means to bring these ideas to life. This partnership, worth $2.6?M, will not only stimulate the implementation of our mutual strategies but also catalyze research in these promising areas in Québec. By helping to make multiple innovations feasible, this initiative allows us to act as drivers of economic development in Québec.”
Read the Press release
Génome Québec announces the appointment of its new Vice President, Technology Centres
Oct. 13, 2021
Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Patrick Blondin, PhD, to the position of Vice President, Technology Centres. Mr. Blondin has all the necessary assets to exceed the objectives of the centres and ensure the competitive use of technological resources operated by Génome Québec. The decision was ratified by the Board of Directors on September 21, 2021. He will assume his position on October 18, 2021.
Three exceptional women join the Génome Québec Board of Directors
Sept. 21, 2021
Génome Québec is extremely proud to welcome Dr. Caroline Quach, Ms. Marie-Paule Jeansonne and Ms. Geneviève Guertin to its Board of Directors.
“I am delighted and proud of these appointments, especially since the three new members, each of them very experienced in their respective areas, will not only help us move forward with our plan to embrace an even more innovative, competitive approach in the coming years but also support our goal of achieving gender equality in keeping with our values,” said Anie Perrault, Chair of the Board.
Read the press release
Genomics: from the lab to the radio
Aug. 23, 2021
On Radio-Canada's program Les années lumière which aired last August 22, researchers Valérie Langlois and Louis Bernatchez were able to popularize the scope of the ITrackDNA project.
Génome Québec is very proud to support these renowned researchers for whom environmental DNA (eDNA) is a wonderful tool to gather accurate information regarding the environment and its biodiversity in a non-invasive way.
To listen to this enriching interview (in French only)
Génome Québec announces an overall investment of $18.4 M in innovative research projects on the environment
July 22, 2021
Génome Québec announced today a total investment of $18.4 million in innovative projects on the environment. The Board of Directors of Genome Canada approved funding for eight Canadian projects under the Genomic Solutions for Natural Resources and the Environment competition with a budget allocation of $58.6 million. Six of the eight projects involve Québec researchers, which means Québec is receiving 31% of the overall budget available nationwide.
The projects will receive close to $4 million in co-funding from Génome Québec, which will be managing them in partnership with Genome British Columbia, Genome Alberta and Ontario Genomics. A total of 19 Québec researchers from various universities are working on these innovative projects that will advance our understanding of biodiversity in Québec and Canada and develop technologies for bioremediation and plastic waste recycling.
To read the press release.
Jennifer Stoddart admitted as Knight of the Ordre national du Québec.
June 28, 2021
As early as 1982, with her solid training as a historian, Jennifer Stoddart distinguished herself by publishing, within the Clio collective, the book L'histoire des femmes au Québec depuis quatre siècles. In the 2000s, she was able to reframe the right to privacy, having served with authority and effectiveness as President of the Commission d'accès à l'information du Québec, and then as Privacy Commissioner of Canada. Since 2014, she has been co-chair of several working committees of the Organisation for Economic Co-operation and Development.
(Text credit: Ordre national du Québec)
Génome Québec annonces an Investment of $4.5 M through the new public-private partnership program for Genomics solutions in Heath
June 21, 2021
A WINNING FORMULA FOR 12 RESEARCH TEAMS
Jan. 29, 2021
Genomics Integration Program - Human Health
Jan. 15, 2021
REQUEST FOR APPLICATIONS - In order to increase the value of genomic discoveries, Génome Québec is offering grants ranging between $50,000 and $200,000 to fund collaborations between academic researchers and partners capable of implementing/commercializing the results of their research. The funds are to be used to establish a proof of concept required to obtain subsequent funding. Projects must be related to Human Health and include at least one aspect derived from “omic” technologies (genomic, epigenomic, metabolomic, metagenomic, nutrigenomic, pharmacogenomic, proteomic, transcriptomic, etc.).